RGS2: a "turn-off" in hypertension.
Publication
, Journal Article
Le, TH; Coffman, TM
Published in: J Clin Invest
February 2003
Duke Scholars
Published In
J Clin Invest
DOI
ISSN
0021-9738
Publication Date
February 2003
Volume
111
Issue
4
Start / End Page
441 / 443
Location
United States
Related Subject Headings
- Vasoconstriction
- Signal Transduction
- RGS Proteins
- Models, Biological
- Mice, Knockout
- Mice
- Immunology
- Hypertension
- Blood Pressure
- Animals
Citation
APA
Chicago
ICMJE
MLA
NLM
Le, T. H., & Coffman, T. M. (2003). RGS2: a "turn-off" in hypertension. J Clin Invest, 111(4), 441–443. https://doi.org/10.1172/JCI17836
Le, Thu H., and Thomas M. Coffman. “RGS2: a "turn-off" in hypertension.” J Clin Invest 111, no. 4 (February 2003): 441–43. https://doi.org/10.1172/JCI17836.
Le TH, Coffman TM. RGS2: a "turn-off" in hypertension. J Clin Invest. 2003 Feb;111(4):441–3.
Le, Thu H., and Thomas M. Coffman. “RGS2: a "turn-off" in hypertension.” J Clin Invest, vol. 111, no. 4, Feb. 2003, pp. 441–43. Pubmed, doi:10.1172/JCI17836.
Le TH, Coffman TM. RGS2: a "turn-off" in hypertension. J Clin Invest. 2003 Feb;111(4):441–443.
Published In
J Clin Invest
DOI
ISSN
0021-9738
Publication Date
February 2003
Volume
111
Issue
4
Start / End Page
441 / 443
Location
United States
Related Subject Headings
- Vasoconstriction
- Signal Transduction
- RGS Proteins
- Models, Biological
- Mice, Knockout
- Mice
- Immunology
- Hypertension
- Blood Pressure
- Animals